2019
DOI: 10.1016/j.fsigen.2019.01.010
|View full text |Cite
|
Sign up to set email alerts
|

Automation and developmental validation of the ForenSeq™ DNA Signature Preparation kit for high-throughput analysis in forensic laboratories

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
28
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 34 publications
3
28
0
Order By: Relevance
“…Furthermore, the detail DoCs for all samples were presented in Supplementary Table S2 and Supplementary Figure S1-S3, which indicated that the DoCs for all samples were balanceable, with no differences for females and males. Our sequencing results were in accordance with other forensic MPS-related studies [40,41,43,45,[111][112][113][114][115]. No matter in females or males, the DoCl and DoCs had no differences at the same locus, and the DoC were unbalanced in different types of genetic markers.…”
Section: Resultssupporting
confidence: 90%
See 1 more Smart Citation
“…Furthermore, the detail DoCs for all samples were presented in Supplementary Table S2 and Supplementary Figure S1-S3, which indicated that the DoCs for all samples were balanceable, with no differences for females and males. Our sequencing results were in accordance with other forensic MPS-related studies [40,41,43,45,[111][112][113][114][115]. No matter in females or males, the DoCl and DoCs had no differences at the same locus, and the DoC were unbalanced in different types of genetic markers.…”
Section: Resultssupporting
confidence: 90%
“…The ForenSeq™ DNA Signature Prep Kit, as the first commercial MPS-based and forensic related kit formally released in 2015, made full use of the MPS method's advantages by means of the simultaneous and compound amplification of either greater than 150 loci including various types of genetic markers. The large-scale performances and functional tests had been widely validated for the ForenSeq™ DNA Signature Prep Kit, the DNA Primer Set A (DPMA, 152 loci totally: 27 common, forensic autosomal STRs, 24 Y-STRs, 7 X-STRs, and 94 identity informative SNPs) and the DNA Primer Set B (in total 230 loci: DMPA plus 22 phenotypic informative SNPs and 56 biogeographical ancestry SNPs), which also include robustness, reproducibility, species specificity, consistency and sensitivity of detection [40][41][42][43][44][45][46][47]. In addition, the applicability of the DNA Signature Prep Kit had been evaluated and verified on challenging samples, DNA mixture, degradative DNA [48][49][50], formalin-fixed paraffin-embedded tissues [49,51], and remains of skeletons and bones [48,[52][53][54], to extend the applications for forensic sciences [55][56][57][58][59][60][61][62][63][64][65][66][67][68].…”
Section: Introductionmentioning
confidence: 99%
“…These markers include identity single nucleotide polymorphisms (iSNPs), phenotype informative single nucleotide polymorphisms (piSNPs), autosomal STRs, YSTRs, and XSTRs. A total of 94 SNPs are used for identification purposes with an additional 76 SNPs which are used for phenotype/ancestry estimation [19]. In this research, we offer an alternative processing workflow optimized for both DNA extraction and amplification to increase positive outcomes with rootless hair samples without having to resort to less discriminatory mitochondrial DNA testing.…”
Section: Introductionmentioning
confidence: 99%
“…Several commercial sequencing panels were developed for human identification, including the ForenSeq TM DNA Signature Prep Kit (Verogen V R , San Diego, CA, USA), the Precision ID GlobalFiler NGS STR Panel (Thermo Fisher Scientific, Waltham, MA, USA), and the PowerSeq TM 46GY System (Promega, Madison, WI, USA). These assays were tested rigorously by different forensic genetic laboratories, and they produced sequencing results that were concordant with CE-based STR typing assays at a level of sensitivity that is comparable to that of the currently used PCR-CE methods [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18].…”
Section: Introductionmentioning
confidence: 99%